Waltham, MA · Health Care · Form D filed Aug 27, 2026

FluidForm Bio, Inc. raised $1.7M

FluidForm Bio, Inc. is a biotechnology company based in Waltham, Massachusetts. In a Form D filed with the SEC on August 27, 2026, it reported raising $1,703,371 from 20 investors as part of an offering of up to $3,000,000. The first sale in the offering took place on July 16, 2026.

Visit website ↗ View the SEC filing Find on LinkedIn People at this company

We build living human tissue using cells, proteins, and nothing else. Our technology leverages the intersection of personalized medicine, synthetic and computational biology, advanced materials,…
In the company's words, from fluidformbio.com

First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
Still raising. $1.3M of the $3M offering was still unsold at filing.

$1.7M raised since 2020

1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.

Filed	Sold	Offering size	Investors
Aug 27, 2026	$1.7M	$3M	20

Lead score

39 out of 100

first raise ever still raising budget to spend website found

Outreach kit How it works 1:21

A first message that shows you did your homework, written from this filing. Fill in the brackets and send.

Email · subject: Congrats on the new round

Hi [first name],

Congrats on the new round. I saw the raise in your SEC filing.

Teams at this stage usually start looking at [what you do] right after a round...

[Your name]

LinkedIn note

Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?

Call opener

Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...

Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing

Track this company How it works 0:56

Saved to your dashboard pipeline, with a badge in Explore.

Loading your outreach kit…

The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.

Start your free trial Already on Pro? Sign in

Filing details

Website: fluidformbio.com
Amount raised: $1,703,371
Offering size: $3,000,000
Investors so far: 20
First sale: July 16, 2026
Securities offered: Equity, Options or warrants
Exemption claimed: Rule 506(b)
Industry: Biotechnology
Headquarters: Waltham, Massachusetts
Incorporated: Delaware
Entity type: Corporation

Filings

Filed	Form	Raised	Offering size	Investors	Source
Aug 27, 2026	D (new notice)	$1,703,371	$3,000,000	20	SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Updated October 14, 2026 · Raises in the week of Aug 24, 2026 · Health Care funding in Massachusetts · August 2026 funding report

Similar raises

All health care raises →

ManufacturingNo press found $10M

AeroShield Materials, Inc.

Waltham, MA · filed Oct 15

5th Form D since 2020Still raising

OtherNo press found $15.5M

Finwave Semiconductor, Inc.

Waltham, MA · filed Oct 8

4th Form D since 2018Still raising

Energy $16.9M

Adden Energy, Inc.

Waltham, MA · filed Oct 5

3rd Form D since 2022Still raising

Health Care $3.8M

Fresenius Medical Care Will Clayton, LLC

Waltham, MA · filed Sep 21

First Form D

Health Care $2.6M

Axelyf, Inc.

Chestnut Hill, MA · filed Oct 13

2nd Form D since 2025

Health Care $850K

Soterya, Inc.

Boston, MA · filed Oct 13

First Form DStill raising

Health CareNo press found $1.2M

Bioventrix, Inc.

Mansfield, MA · filed Oct 8

OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart Failure Patients How Revivent Therapy May…

26th Form D since 2009Still raising

Health Care $15M

Revbio, Inc.

Lowell, MA · filed Oct 2

TETRANITE is a regenerative bone glue. Bioengineered for a body of applications, TETRANITE® promises to transform bone repair.

4th Form D since 2019